Effect of Stress Management Training on Stigma and Social Phobia in HIV-Positive Women

Shamsaei, Farshid; Tahour, Neda; Sadeghian, Efat

doi:10.1177/2325958220918953

Cited by 5 publications

(2 citation statements)

References 32 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The included studies recruited a total of 68,933 participants, with individual sample sizes ranging from 14 in Rwanda [ 98 ] to 2987 in China [ 187 ]. The recruited participants included diverse samples of PLWH, including adolescents and young adults living with HIV in 12 studies [ 22 , 23 , 38 , 62 , 72 , 80 , 83 , 125 , 126 , 129 , 163 , 178 ], adolescent girls and young women living with HIV in four studies [ 33 , 54 , 68 , 117 ], pregnant women living with HIV in one study [ 31 ], older women living with HIV in one study [ 151 ], older adults living with HIV in seven studies [ 44 , 61 , 63 , 77 , 81 , 139 , 161 ], women living with HIV in 19 studies [ 25 , 42 , 50 , 57 , 58 , 59 , 89 , 90 , 110 , 123 , 135 , 136 , 138 , 141 , 157 , 158 , 168 , 169 , 179 ], men living with HIV in six studies [ 46 , 75 ,…”

Section: Resultsmentioning

confidence: 99%

Psychometric Properties of the Berger HIV Stigma Scale: A Systematic Review

Wanjala

Too

Luchters

et al. 2021

IJERPH

View full text Add to dashboard Cite

Addressing HIV-related stigma requires the use of psychometrically sound measures. However, despite the Berger HIV stigma scale (HSS) being among the most widely used measures for assessing HIV-related stigma, no study has systematically summarised its psychometric properties. This review investigated the psychometric properties of the HSS. A systematic review of articles published between 2001 and August 2021 was undertaken (CRD42020220305) following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Additionally, we searched the grey literature and screened the reference lists of the included studies. Of the total 1241 studies that were screened, 166 were included in the review, of which 24 were development and/or validation studies. The rest were observational or experimental studies. All the studies except two reported some aspect of the scale’s reliability. The reported internal consistency ranged from acceptable to excellent (Cronbach’s alpha ≥ 0.70) in 93.2% of the studies. Only eight studies reported test–retest reliability, and the reported reliability was adequate, except for one study. Only 36 studies assessed and established the HSS’s validity. The HSS appears to be a reliable and valid measure of HIV-related stigma. However, the validity evidence came from only 36 studies, most of which were conducted in North America and Europe. Consequently, more validation work is necessary for more precise insights.

show abstract

Section: Resultsmentioning

confidence: 99%

Psychometric Properties of the Berger HIV Stigma Scale: A Systematic Review

Wanjala

Too

Luchters

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…The evidence review identified 70 intervention evaluations [29–98]. The literature flow is documented below (Fig.…”

Section: Resultsmentioning

confidence: 99%

Systematic review and quantitative and qualitative comparative analysis of interventions to address HIV-related stigma and discrimination

Ferguson

Gruskin

Bolshakova

et al. 2023

Aids

View full text Add to dashboard Cite

A strong global commitment exists to eliminate HIV-related stigma and discrimination, and multiple strategies to reduce or eliminate stigma and discrimination have been tried. Using a PICOTS framework and applying the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria, we undertook a systematic review to determine the success of interventions aiming to address internalized stigma, stigma and discrimination in healthcare, and at the legal or policy level, and to identify their critical success factors. Random effects meta-analyses summarized results wherever possible. We carried out a component analysis to identify and characterize successful interventions. Internalized stigma interventions were diverse: across all studies, we found a reduction of stigma but it was not statistically significant [standardized mean difference (SMD) 0.56; confidence interval (CI) 0.31-1.02; 17 studies). For interventions to address stigma and discrimination in healthcare settings, effect estimates varied considerably but most studies showed positive effects (SMD 0.71; CI 0.60-0.84, 8 studies). Boosted regression analyses found that a combined approach comprising education, counseling, community participation, support person, and access to a HIV specialist often yielded success. Studies of efforts to address stigma and discrimination through law and policy documented, mostly qualitatively, the effect of court cases and directives. Across a range of settings and populations, promising interventions have been identified that, through diverse pathways, have positively impacted the types of stigma and discrimination studied. This evidence base must be built upon and brought to scale to help reach global HIV-related targets and, most importantly, improve the health and quality of life of people with HIV.

show abstract